跳至主要内容
临床试验/NCT02946476
NCT02946476已完成不适用

Prevalence and Prognostic Impact of Noncardiac Comorbidities in Heart Failure Outpatients With Preserved and Reduced Ejection Fraction: A Community-Based Study

Ospedale Maggiore Di Trieste0 个研究点目标入组 2,314 人开始时间: 2009年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
2,314
主要终点
overall mortality

研究概览

简要总结

To better understand the public health prognostic impact of noncardiac chronic illnesses, we explored the attributable risk of noncardiac comorbidities on outcomes between heart failure patients with reduced ejection fraction (HFREF) and heart failure patients with preserved ejection fraction (HFpEF) in a large contemporary heart failure (HF) population The adjusted hazard ratio (HR) and the population attributable risk were used to compare the contributions of 15 noncardiac comorbidities to adverse outcome. The comorbidities that contributed to high attributable risk were: anemia, chronic kidney disease, chronic obstructive pulmonary disease, diabetes mellitus, and peripheral artery disease. These findings were similar for HFrEF and HFpEF groups. Interaction analysis confirmed similar results.

研究设计

研究类型
Observational
观察模型
Ecologic Or Community
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All consecutive heart failure patients with left ventricular ejction fraction available before or within 3 months from the index visit

排除标准

  • We excluded all patients who had severe primary left-sided valvular disease

结局指标

主要结局

overall mortality

时间窗: 2 years

次要结局

  • noncardiovascular hospitalization(2 years)
  • First all-cause hospitalization(2 years)
  • Heart Failure hospitalization(2 years)

研究者

发起方
Ospedale Maggiore Di Trieste
申办方类型
Other
责任方
Principal Investigator
主要研究者

Annamaria Iorio

Principal Investigator

Ospedale Maggiore Di Trieste

相似试验